Metabolic Flexibility Permits Mesenchymal Stem Cell Survival in an Ischemic Environment

The application of mesenchymal stem cells (MSCs) for myocardial repair following ischemic injury is of strong interest, but current knowledge regarding the survival and retention of differentiation potency of stem cells under ischemic conditions is limited. The present study investigated the effects of ischemia and its components (hypoxia and glucose depletion) on MSC viability and multipotency. We demonstrate that MSCs have a profoundly greater capacity to survive under conditions of ischemia compared with cardiomyocytes, measured by detecting changes in cellular morphology, caspase activity and phosphatidylserine exposure. MSCs were also resistant to exposure to hypoxia (0.5% O2), as well as inhibition of mitochondrial respiration with 2,4‐dinitrophenol for 72 hours, indicating that in the absence of oxygen, MSCs can survive using anaerobic ATP production. Glucose deprivation (glucose‐free medium in combination with 2‐deoxyglucose) induced rapid death of MSCs. Depletion of cellular ATP occurred at a lower rate during glucose deprivation than during ischemia, suggesting that glycolysis has specific prosurvival functions, independent of energy production in MSCs. After exposure to hypoxic or ischemic conditions, MSCs retained the ability to differentiate into chondrocytes and adipocytes and, more importantly, retained cardiomyogenic potency. These results suggest that MSCs are characterized by metabolic flexibility, which enables them to survive under conditions of ischemic stress and retain their multipotent phenotype. These results highlight the potential utility of MSCs in the treatment of ischemic disease.

[1]  Nan Ma,et al.  Bcl‐2 Engineered MSCs Inhibited Apoptosis and Improved Heart Function , 2007, Stem cells.

[2]  R. Zhao,et al.  Proliferation and differentiation of bone marrow stromal cells under hypoxic conditions. , 2006, Biochemical and biophysical research communications.

[3]  D. Prockop,et al.  Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Gianluca Gallo,et al.  Reevaluation of in vitro differentiation protocols for bone marrow stromal cells: Disruption of actin cytoskeleton induces rapid morphological changes and mimics neuronal phenotype , 2004, Journal of neuroscience research.

[5]  Paul D. Kessler,et al.  Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart , 2002, Circulation.

[6]  M. Rovetto,et al.  Mechanisms of Glycolytic Inhibition in Ischemic Rat Hearts , 1975, Circulation research.

[7]  A M Mackay,et al.  Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. , 1998, Tissue engineering.

[8]  A. Caplan,et al.  Cultivation of rat marrow‐derived mesenchymal stem cells in reduced oxygen tension: Effects on in vitro and in vivo osteochondrogenesis , 2001, Journal of cellular physiology.

[9]  J. Ingwall,et al.  Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts , 2003, Nature Medicine.

[10]  R. Gottlieb,et al.  Ischemia/reperfusion injury at the intersection with cell death. , 2005, Journal of molecular and cellular cardiology.

[11]  F. Gao,et al.  A promising strategy for the treatment of ischemic heart disease: Mesenchymal stem cell-mediated vascular endothelial growth factor gene transfer in rats. , 2007, The Canadian journal of cardiology.

[12]  M. Hori,et al.  Induction of manganese superoxide dismutase in rat cardiac myocytes increases tolerance to hypoxia 24 hours after preconditioning. , 1994, The Journal of clinical investigation.

[13]  Shengshou Hu,et al.  Hypoxia and Serum Deprivation‐Induced Apoptosis in Mesenchymal Stem Cells , 2006, Stem cells.

[14]  H. Kofoed,et al.  Bone marrow circulation after osteotomy. Blood flow, pO2, pCO2, and pressure studied in dogs. , 1985, Acta orthopaedica Scandinavica.

[15]  D. Prockop,et al.  One strategy for cell and gene therapy: Harnessing the power of adult stem cells to repair tissues , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Bernd Hertenstein,et al.  Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial , 2004, The Lancet.

[17]  J. Ingwall,et al.  Evidence supporting paracrine hypothesis for Akt‐modified mesenchymal stem cell‐mediated cardiac protection and functional improvement , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  Janice L. V. Reeve,et al.  Don't lose heart ‐ therapeutic value of apoptosis prevention in the treatment of cardiovascular disease , 2005, Journal of cellular and molecular medicine.

[19]  J. Daut,et al.  Long-chain fatty acids increase basal metabolism and depolarize mitochondria in cardiac muscle cells. , 2002, American journal of physiology. Heart and circulatory physiology.

[20]  P. Mitchell,et al.  Acid-base titration across the membrane system of rat-liver mitochondria. Catalysis by uncouplers. , 1967, The Biochemical journal.

[21]  P. Gao,et al.  Passage-restricted differentiation potential of mesenchymal stem cells into cardiomyocyte-like cells. , 2005, Biochemical and biophysical research communications.

[22]  Afshin Samali,et al.  Cytokine-induced β-cell apoptosis is NO-dependent, mitochondria-mediated and inhibited by BCL-XL , 2007, Journal of cellular and molecular medicine.

[23]  Afshin Samali,et al.  TRAIL sensitisation by arsenic trioxide is caspase-8 dependent and involves modulation of death receptor components and Akt , 2006, British Journal of Cancer.

[24]  F. Barry,et al.  Mesenchymal stem cells: clinical applications and biological characterization. , 2004, The international journal of biochemistry & cell biology.

[25]  C. Murry,et al.  Regenerating the heart , 2005, Nature Biotechnology.

[26]  Janice L. V. Reeve,et al.  Distinct mechanisms of cardiomyocyte apoptosis induced by doxorubicin and hypoxia converge on mitochondria and are inhibited by Bcl-xL , 2007, Journal of cellular and molecular medicine.

[27]  P. Hammerman,et al.  Akt-Directed Glucose Metabolism Can Prevent Bax Conformation Change and Promote Growth Factor-Independent Survival , 2003, Molecular and Cellular Biology.

[28]  Afshin Samali,et al.  Losing heart: the role of apoptosis in heart disease—a novel therapeutic target? , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  W. Baumgartner,et al.  Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. , 2002, The Annals of thoracic surgery.

[30]  R. Jennings,et al.  The cell biology of acute myocardial ischemia. , 1991, Annual review of medicine.

[31]  C. Thompson,et al.  Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. , 2004, Molecular cell.

[32]  S. Ogawa,et al.  Cardiomyocytes can be generated from marrow stromal cells in vitro. , 1999, The Journal of clinical investigation.

[33]  Feng Zhao,et al.  Effects of hypoxia on human mesenchymal stem cell expansion and plasticity in 3D constructs , 2006, Journal of cellular physiology.

[34]  Zhi-Qing Zhao.  Oxidative stress-elicited myocardial apoptosis during reperfusion. , 2004, Current opinion in pharmacology.

[35]  A. Friedenstein,et al.  Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers , 1987, Cell and tissue kinetics.

[36]  Arjun Deb,et al.  Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[37]  Feng Zhao,et al.  Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. , 2007, Biochemical and biophysical research communications.

[38]  M. Baumann,et al.  A number of bone marrow mesenchymal stem cells but neither phenotype nor differentiation capacities changes with age of rats. , 2007, Molecules and cells.

[39]  Afshin Samali,et al.  ER stress contributes to ischemia-induced cardiomyocyte apoptosis. , 2006, Biochemical and biophysical research communications.